Antibody Drug Conjugates for Cancer

Antibody-drug conjugates (ADC) represent a new way to treat cancer. ADC are comprised of an antibody, a linker, and a payload. Unlike traditional chemotherapy, ADC are targeted to impair cancer cells, while sparing healthy cells. In this course, we discuss how ADC were developed, and their mechanism of action. We also review several different ADC therapies and the differences between them. Come discover why ADC are of the fastest growing cancer therapies and how they will affect our patients.
Speaker: Dr. Hossein Borghaei
To earn 1 hour of free COPE approved enduring CE in the pharmacology category, please visit our site and take the post test: woou.eyecarepro.com/

[@christophersandmann]

Thanks for your hard work in making this happen. Really good stuff.

[@ajuwatcher]

Great presentation by Dr. Borghaei on this new and hot topic. I am so glad it was uploaded to KZbin for people like me who are interested in this topic to view for free! I was wonder though, is there a way to get a hold of the presentation slides by Dr. Borghaei? I would love to use the information for knowledge sharing.

[@MrCmusicfan]

Great talk!!